Recent headlines warning of concerns such as heart risks or danger to teenagers have put a new spotlight on a diet trend that ...

Whether intermittent fasting helps anyone is unclear, but it does have known health risks. Who can try the dieting trend, and ...

A new study recently put this popular eating plan to the test —  and the results were surprising. Here’s what you need to ...

Past research has suggested that myo-inositol may benefit pregnant women with PCOS and reduce risk of complications. PCOS patients are prone to abnormal glucose regulation and myo-inositol has ...

ProKidney Corp. ( NASDAQ: PROK) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:00 AM EDT ...

Learning is a complex process — and so is measuring it. Though research shows we have cause to be concerned about what ...

A large-scale study of nearly 150,000 individuals has found that starting drug treatment for attention deficit hyperactivity ...

Experts weigh in on the use of real-world evidence (RWE) in pain research, providing recommendations for rigorous study design, analysis, and reporting to ensure data validity and credibility.

Explore Zentalis’ latest oncology advances and azenosertib updates for ovarian cancer from the 2025 Morgan Stanley Healthcare Conference.

HHS has a tremendous opportunity to ensure that both government and private insurers are paying for oncology treatments ...

FDA alignment on Phase 3 ozuriftamab vedotin (Oz-V) trial design, including dosing regimen and endpoints to support potential accelerated ...

On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control ...